Circadian rhythms and cardiac physiology: An essential interplay.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and genetic studies without systematic methodology or new human clinical data.
PubMed 40390462 · doi:10.1016/bs.ircmb.2024.07.001
What was done
This narrative review summarizes existing literature on the role of molecular circadian clocks in cardiac physiology. It examines the effects of whole-body and cardiomyocyte-specific clock gene manipulations and reviews evidence across diverse cardiac cell types, including cardiomyocytes, endothelial cells, fibroblasts, and immune cells, while exploring implications for cardiovascular chronotherapy.
What was found
The abstract provides no quantitative data or specific numerical metrics. It reports that genetic disruption of clock genes alters cardiac function and highlights established mechanistic links between core clock components and cardiomyocyte-specific genes, while noting that data regarding clock function in non-cardiomyocyte cell populations in the heart remain extremely limited.
Why it matters
Understanding the cell-type-specific temporal regulation of heart tissue may identify novel targets for cardiovascular chronotherapies and optimize the timing of existing interventions.
Limits
The abstract describes a narrative overview rather than a systematic review with meta-analysis. It provides no quantitative synthesis, sample sizes, or study counts, and highlights a substantial knowledge deficit regarding non-cardiomyocyte cell populations in cardiac tissue.
Cited by
- supports Every cell in the human body contains internal circadian clocks.